The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis

Pierre O’Brien; Kara Matheson; Alwin Jeyakumar; Kim Anderson; Tallal Younis

doi:10.1007/s10549-018-05114-7

The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis

Pierre O’Brien, Kara Matheson, Alwin Jeyakumar, Kim Anderson, Tallal Younis

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	357-363
Number of pages	7
Journal	Breast Cancer Research and Treatment
Volume	174
Issue number	2
DOIs	https://doi.org/10.1007/s10549-018-05114-7
Publication status	Published - Apr 15 2019
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Cancer Research

Keywords

Anthracyclines
Breast cancer
Cardiotoxicity
Routine
Screening

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10549-018-05114-7

Cite this

The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis. / O’Brien, Pierre; Matheson, Kara; Jeyakumar, Alwin et al.
In: Breast Cancer Research and Treatment, Vol. 174, No. 2, 15.04.2019, p. 357-363.

Research output: Contribution to journal › Review article › peer-review

@article{11238aaab182435c838256101e645ae9,

title = "The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis",

keywords = "Anthracyclines, Breast cancer, Cardiotoxicity, Routine, Screening",

author = "Pierre O{\textquoteright}Brien and Kara Matheson and Alwin Jeyakumar and Kim Anderson and Tallal Younis",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2019",

month = apr,

day = "15",

doi = "10.1007/s10549-018-05114-7",

language = "English",

volume = "174",

pages = "357--363",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

number = "2",

}

TY - JOUR

T1 - The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer

T2 - a systematic review and meta-analysis

AU - O’Brien, Pierre

AU - Matheson, Kara

AU - Jeyakumar, Alwin

AU - Anderson, Kim

AU - Younis, Tallal

PY - 2019/4/15

Y1 - 2019/4/15

KW - Anthracyclines

KW - Breast cancer

KW - Cardiotoxicity

KW - Routine

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85059689053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059689053&partnerID=8YFLogxK

U2 - 10.1007/s10549-018-05114-7

DO - 10.1007/s10549-018-05114-7

M3 - Review article

C2 - 30603999

AN - SCOPUS:85059689053

SN - 0167-6806

VL - 174

SP - 357

EP - 363

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 2

ER -

The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this